$3.05
0.06[2.01%]
Last update: 9:20AM Get Real Time Here
PDS Biotechnology
(NASDAQ:PDSB)Latest News for PDS Biotechnology Stock (NASDAQ:PDSB)
PDS Biotechnology Stock (NASDAQ: PDSB)
Categories: All
Thursday, March 28, 2024
Wednesday, March 27, 2024
- PDS Biotechnology shares are trading lower. The company reported Q4 financial results.Benzinga Newsdesk - Mar 27, 2024, 1:20PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Mar 27, 2024, 12:31PM
- HC Wainwright & Co. Maintains Buy on PDS Biotechnology, Maintains $21 Price TargetBenzinga Newsdesk - Mar 27, 2024, 10:28AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Mar 27, 2024, 9:05AM
- PDS Biotechnology Q4 EPS $(0.35) Beats $(0.44) Estimate; Cash Balance $56.6MBenzinga Newsdesk - Mar 27, 2024, 7:38AM
- Earnings Scheduled For March 27, 2024Benzinga Insights - Mar 27, 2024, 5:02AM
Tuesday, March 26, 2024
Wednesday, March 13, 2024
Tuesday, November 28, 2023
Wednesday, November 15, 2023
Tuesday, November 14, 2023
- PDS Biotechnology shares are trading higher after the company reported Q3 financial results.Benzinga Newsdesk - Nov 14, 2023, 2:23PM
- Earnings Scheduled For November 14, 2023Benzinga Insights - Nov 14, 2023, 8:23AM
- PDS Biotech Says Its Available Cash Resources Will Sustain Operational, Research & Development Endeavors Into Q3 Of 2024Benzinga Newsdesk - Nov 14, 2023, 7:40AM
- PDS Biotechnology: Q3 Earnings InsightsBenzinga Insights - Nov 14, 2023, 7:35AM
- PDS Biotechnology Q3 EPS $(0.35) Vs. $(0.26) Last YearBenzinga Newsdesk - Nov 14, 2023, 7:32AM
Monday, November 13, 2023
Monday, October 23, 2023
Wednesday, October 11, 2023
- The Latest Analyst Ratings for PDS BiotechnologyBenzinga Insights - Oct 11, 2023, 1:00PM
- HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price TargetBenzinga Newsdesk - Oct 11, 2023, 12:37PM
- PDS Biotech Announces Interim Safety and Immune Response Data from Phase 1/2 Clinical Trial Evaluating Novel Antibody Drug Conjugate PDS0301 Combined with Docetaxel to Treat Metastatic Prostate CancerBenzinga Newsdesk - Oct 11, 2023, 8:03AM
Wednesday, October 04, 2023
Monday, October 02, 2023
Wednesday, September 27, 2023
Wednesday, September 20, 2023
Wednesday, August 16, 2023
Monday, August 14, 2023
- HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price TargetBenzinga Newsdesk - Aug 14, 2023, 11:05AM
- PDS Biotechnology Q2 EPS $(0.37), Inline; Cash and Equivalents $60.6M Sufficient to Fund R&D Aug. 2024Benzinga Newsdesk - Aug 14, 2023, 7:35AM
- PDS Biotech Announces Submission Of Phase 3 Protocol To FDA To Initiate VERSATILE-003 TrialBenzinga Newsdesk - Aug 14, 2023, 7:18AM
- Earnings Scheduled For August 14, 2023Benzinga Insights - Aug 14, 2023, 6:45AM
Friday, August 11, 2023
Tuesday, July 25, 2023
- PDS Biotechnology – Top-Line Data From Its Lead Candidate Points To Promising Future For This CompanyJohnny Rice - Jul 25, 2023, 12:14PM
- PDS Biotechnology's Abstract Detailing Immune Response Data From The VERSATILE-002 Phase 2 Trial Of PDS0101 Combined With Merck's Keytruda (Pembrolizumab), In Head & Neck Cancer Has Been Accepted For Presentation At The ESMO Congress 2023Benzinga Newsdesk - Jul 25, 2023, 8:16AM
Tuesday, July 11, 2023
Tuesday, June 20, 2023
Tuesday, June 06, 2023
Monday, June 05, 2023
Monday, May 29, 2023
Friday, May 26, 2023
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - May 26, 2023, 1:31PM
- Why Hibbett Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - May 26, 2023, 12:48PM
- PDS Biotechnology shares are trading higher after the company announced 12-month survival data for PDS0101 in combination with KEYTRUDA.Bill Haddad - May 26, 2023, 11:37AM